Roldan, Carlos J.
Huh, Billy
Song, Juhee
Nieto, Yago
Osei, Joyce
Chai, Thomas
Nouri, Kent
Koyyalagunta, Lakshmi
Bruera, Eduardo
Article History
Received: 1 June 2022
Accepted: 26 September 2022
First Online: 3 November 2022
Declarations
:
: Data was collected in accordance with the Declaration of Helsinki. It was approved by the MD Anderson institutional IRB. Protocol Number: 2016-1051.Trial registration ClinicalTrials.gov ID: NCT03469284.
: Not applicable.
: Carlos Roldan MD is currently applying for a patent on the use of Methylene blue for oral pain in mucositis associated to cancer therapy. The application process is not depending on the content of the manuscript. The rest of the authors declare that they have no competing interests.